Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: Relevance for chronic obstructive pulmonary disease therapy

Journal of Immunology

Volumn 170, Issue 5, 2003, Pages 2663-2669

  Patel, Hema J ^a,d   Belvisi, Maria G ^a   Bishop Bailey, David ^c   Yacoub, Magdi H ^a   Mitchell, Jane A ^b  

^a Department of Cardiothoracic Surgery   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

AIRWAY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; CELL GROWTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; HUMAN CELL; HYPERPLASIA; HYPERTROPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SMOOTH MUSCLE FIBER;

EID: 0037373271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.5.2663     Document Type: Article

References (51)

1. Jeffery, P. K. 2000. Comparison of the structural and inflammatory features of COPD and asthma: Giles F. Filley lecture. Chest 117:251S.
2. John, M., B. T. Au, P. J. Jose, S. Lim, M. Saunders, P. J. Barnes, J. A. Mitchell, M. G. Belvisi, and K. F. Chung. 1998. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am. J. Respir. Cell Mol. Biol. 18:84.
3. Chung, K. F., H. J. Patel, E. J. Fadlon, J. Rousell, E. B. Haddad, P. J. Jose, J. Mitchell, and M. Belvisi. 1999. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: effects of IL-10 and corticosteroids. Br. J. Pharmacol. 127:1145.
4. Belvisi, M. G., M. A. Saunders, E. B. Haddad, S. J. Hirst, M. H. Yacoub, P. J. Barnes, and J. A. Mitchell. 1997. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br. J. Pharmacol. 120:910.
5. Patel, H. J., M. G. Belvisi, L. E. Donnelly, M. H. Yacoub, K. F. Chung, and J. A. Mitchell. 1999. Constitutive expressions of type I NOS in human airway smooth muscle cells: evidence for an antiproliferative role. FASEB J. 13:1810.
6. Saunders, M. A., J. A. Mitchell, P. M. Seldon, M. H. Yacoub, P. J. Barnes, M. A. Giembycz, and M. G. Belvisi. 1997. Release of granulocyte- macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120:545.
7. Clarke, D. L., H. J. Patel, J. A. Mitchell, M. H. Yacoub, M. A. Giembycz, and M. G. Belvisi. 2001. Regulation of the release of colony-stimulating factors from human airway smooth muscle cells by prostaglandin E2. Br. J. Pharmacol. 133:40P.
8. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220.
9. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012.
10. Issemann, I., and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645.
11. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879.
12. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, β, and -γ in the adult rat. Endocrinology 137:354.
13. Spiegelman, B. M., and J. S. Flier. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87:377.
14. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91:7355.
15. Mukherjee, R., L. Jow, G. E. Croston, and J. R. Patemiti, Jr. 1997. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272:8071.
16. Serhan, C. N. 1996. Inflammation: signalling the fat controller. Nature 384:23.
17. Staels, B., W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart. et al. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393:790.
18. Delerive, P., K, De Bosscher, S. Besnard, W. Vanden Berghe, J. M. Peters, F. J. Gonzalez, J. C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels. 1999. Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J. Biol. Chem. 274:32048.
19. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82.
20. Wang, A. C., X. Dai, B. Luu, and D. J. Conrad. 2001. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am. J. Respir. Cell Mol. Biol. 24:688.
21. Law, R. E., W. P. Meehan, X. P. Xi, K. Graf, D. A. Wuthrich, W. Coats, D. Faxon, and W. A. Hsueh. 1996. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1897.
22. 2. J. Biol. Chem. 274:17042.
23. Bishop-Bailey, D., T. Hla, and T. D. Warner. 2001. Peroxisome proliferator-activated (PPAR)-γ ligands induce vascular smooth muscle cell apoptosis. Br. J. Pharmacol. 133:29P.
24. Clarke, R. B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. Padula. 2000. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses. J. Immunol. 164:1346.
25. Harris, S. G., and R. P. Phipps. 2001. The nuclear receptor PPARγ is expressed by mouse T lymphocytes and PPARγ agonists induce apoptosis. Eur. J. Immunol. 31:1098.
26. Chinetti, G., S. Griglio, M, Antonucci, I. P. Torra, P. Delerive, Z. Majd, J. C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem, 273:25573.
27. Hirst, S. J., P. J. Barnes, and C. H. Twort. 1992. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor, Am. J. Respir. Cell Mol. Biol. 7:574.
28. Auboeuf, D., J. Rieusset, L. Fajas, P. Vallier, V. Frering, J. P. Riou, B. Staels, J, Auwerx, M. Laville, and H. Vidal. 1997. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319.
29. Bishop-Bailey, D., T. Hla, and T. D. Warner. 2002. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-γ ligand therapy. Circ. Res. 91:210.
30. Stanford, S. J., J. R. Pepper, and J. A. Mitchell. 2000. Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2. Br. J. Pharmacol. 129:835.
31. Belvisi, M. G., M. Saunders, M. Yacoub, and J. A. Mitchell. 1998. Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth, Br. J, Pharmacol. 125:1102.
32. Hashiramoto, A., H. Sano, T. Maekawa, Y, Kawahito, S. Kimura, Y. Kusaka, R. L. Wilder, H. Kato, M. Kondo, and H. Nakajima. 1999. c-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 42:954.
33. Culpitt, S. V., and D. F. Rogers. 2000. Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease. Expert. Opin. Phannacother. 1:1007.
34. Barnes, P. J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:868.
35. Broide, D. H., and G. S. Firestein. 1991. Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J. Clin. Invest. 88:1048.
36. Brown, P. H., G. K. Crompton, and A. P. Greening. 1991. Proinflammatory cytokines in acute asthma. Lancet 338:590.
37. Woolley, K. L., E. Adelroth, M. J. Woolley, R. Ellis, M. Jordana, and P. M. O'Byme. 1995. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma. Am. J. Respir. Crit. Care Med. 151:1915.
38. Sullivan, S., and D. H. Broide. 1996. Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J. Allergy Clin. Immunol. 97:966.
39. Lei, X. F., Y. Ohkawara, M. R. Stampfli, J. Gauldie, K. Croitoru, M. Jordana, and Z. Xing. 1998. Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin. Exp. Immunol. 113:157.
40. Stanford, S. J., J. R. Pepper, A. Burke-Gaffney, and J. A. Mitchell. 2001. Cytokine-activated human vascular smooth muscle delays apoptosis of neutrophils: relevance of interactions between cyclo-oxygenase-2 and colony-stimulating factors. FASEB J. 15:1813.
41. Aggarwal, A., C. S. Baker, T. W. Evans, and P. L. Haslam. 2000. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur. Respir. J. 15:895.
42. Tsubouchi, Y., H. Sano, Y. Kawahito, S. Mukai, R. Yamada, M. Kohno, K. Inoue, T. Hla, and M. Kondo. 2000. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis. Biochem. Biophys. Res. Commun. 270:400.
43. Bishop-Bailey, D. 2000. Peroxisome proliferator-activated receptors in the cardiovascular system, Br. J. Pharmacol. 129:823.
44. 2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell 83:813.
45. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106:189.
46. Jackson, S. M., F. Parhami, X. P. Xi, J. A. Berliner, W. A. Hsueh1, R. E. Law, and L. L. Demer. 1999. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler. Thromb. Vasc. Biol. 19:2094.
47. Hamann, K. J., J. E. Vieira, A. J. Halayko, D. Dorscheid, S. R. White, S. M. Forsythe, B. Camoretti-Mercado, K. F. Rabe, and J. Solway. 2000. Fas cross-linking induces apoptosis in human airway smooth muscle cells. Am. J. Physiol. 278:L618.
48. Marx, N., G. K. Sukhova, T. Collins, P. Libby, and J. Plutzky. 1999. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99:3125.
49. Neve, B. P., D. Corseaux, G. Chinetti, C. Zawadzki, J. C. Fruchart, P. Duriez, B. Staels, and B. Jude. 2001. PPARa agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103:207.
50. Su, C. G., X. Wen, S. T. Bailey, W. Jiang, S. M. Rangwala, S. A. Keilbaugh, A. Flanigan, S. Murthy, M. A. Lazar, and G. D. Wu. 1999. A novel therapy for colitis utilizing PPARγ ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104:383.
51. Desreumaux, P., L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, K. Schoonjans, B. Derijard, B. Desvergne, W. Wahli, P. Chambon. et al. 2001. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor-γ (PPARγ) heterodimer: a basis for new therapeutic strategies. J. Exp. Med. 193:827.